Back to search
FDAFDA · Food and drugs·Recall number D-1517-2019

Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL), 16 fl. oz. (473 mL) bottle, Rx only, Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 27808-086-02.

Published July 31, 2019 · Recall initiated: July 11, 2019

Summary

FDA records drug Class II recall D-1517-2019, published July 31, 2019 and initiated July 11, 2019. Recalling firm: Tris Pharma Inc.; Status: Terminated; Reported quantity: 2,550 bottles; Lot: Lot#: 14079, Exp 10/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
Manufacturer
Tris Pharma Inc.
Distributor
Nationwide in the USA and Puerto Rico
UPC
0327808086013
Lot
Lot#: 14079, Exp 10/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL), 16 fl. oz. (473 mL) bottle, Rx only, Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 27808-086-02. recalled?

Yes. FDA published recall D-1517-2019 on July 31, 2019. Reported hazard: Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX. UPC: 0327808086013.